T cell signaling targets for enhancing regulatory or effector function

Science Signaling

Volumn 5, Issue 235, 2012, Pages

  Pan, Fan ^a   Fan, Huimin ^b   Liu, Zhongmin ^b   Jiang, Shuiping ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TONGJI UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HISTONE ACETYLTRANSFERASE; HISTONE DEACETYLASE 6; HISTONE DEACETYLASE INHIBITOR; INTERLEUKIN 2; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROGRAMMED DEATH 1 RECEPTOR; S PHASE KINASE ASSOCIATED PROTEIN 2; SIRTUIN 1; TRANSCRIPTION FACTOR FOXP3;

CELL CYCLE PROGRESSION; CELL EXPANSION; CELL PROLIFERATION; CELL THERAPY; DNA METHYLATION; EFFECTOR CELL; EPIGENETICS; G1 PHASE CELL CYCLE CHECKPOINT; GENE EXPRESSION; GENE MUTATION; GENETIC TRANSCRIPTION; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HISTONE ACETYLATION; HUMAN; IMMUNOTHERAPY; INTRACELLULAR SIGNALING; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE ACTIVATION; TUMOR IMMUNITY; VIRUS IMMUNITY;

CELL DIFFERENTIATION; EPIGENESIS, GENETIC; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HISTONE DEACETYLASES; HUMANS; LYMPHOCYTE ACTIVATION; MODELS, IMMUNOLOGICAL; SIGNAL TRANSDUCTION; T-LYMPHOCYTES, REGULATORY;

EID: 84864556943     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2003364     Document Type: Review

References (28)

1. R. V. Parry, J. M. Chemnitz, K. A. Frauwirth, A. R. Lanfranco, I. Braunstein, S. V. Kobayashi, P. S. Linsley, C. B. Thompson, J. L. Riley, CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell. Biol. 25, 9543-9553 (2005).
2. L. M. Francisco, V. H. Salinas, K. E. Brown, V. K. Vanguri, G. J. Freeman, V. K. Kuchroo, A. H. Sharpe, PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206, 3015-3029 (2009).
3. L. M. Francisco, P. T. Sage, A. H. Sharpe, The PD-1 pathway in tolerance and autoimmunity. Immunol. Rev. 236, 219-242 (2010).
4. N. Patsoukis, J. Brown, V. Petkova, F. Liu, L. Li, V. A. Boussiotis, Selective effects of PD-1 on Akt and Ras pathways regulate molecular components of the cell cycle and inhibit T cell proliferation. Sci. Signal. 5, ra46 (2012).
5. S. Sakaguchi, N. Sakaguchi, M. Asano, M. Itoh, M. Toda, Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155, 1151-1164 (1995).
6. M. Asano, M. Toda, N. Sakaguchi, S. Sakaguchi, Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation. J. Exp. Med. 184, 387-396 (1996).
7. A. M. Thornton, E. M. Shevach, CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med. 188, 287-296 (1998).
8. K. Wing, S. Sakaguchi, Regulatory T cells exert checks and balances on self tolerance and autoimmunity. Nat. Immunol. 11, 7-13 (2010).
9. D. R. Littman, A. Y. Rudensky, Th17 and regulatory T cells in mediating and restraining inflammation. Cell 140, 845-858 (2010).
10. D. J. Campbell, M. A. Koch, Phenotypical and functional specialization of FOXP3+ regulatory T cells. Nat. Rev. Immunol. 11, 119-130 (2011).
11. M. Feuerer, J. A. Hill, D. Mathis, C. Benoist, Foxp3+ regulatory T cells: Differentiation, specification, subphenotypes. Nat. Immunol. 10, 689-695 (2009).
12. S. Sakaguchi, M. Miyara, C. M. Costantino, D. A. Hafler, FOXP3+ regulatory T cells in the human immune system. Nat. Rev. Immunol. 10, 490-500 (2010).
13. J. J. O'Shea, W. E. Paul, Mechanisms underlying lineage commitment and plasticity of helper CD4+ T cells. Science 327, 1098-1102 (2010).
14. H. Fan, P. Cao, D. S. Game, F. Dazzi, Z. Liu, S. Jiang, Regulatory T cell therapy for the induction of clinical organ transplantation tolerance. Semin. Immunol. 23, 453-461 (2011).
15. P. Trzonkowski, M. Bieniaszewska, J. Ju?ci?ska, A. Dobyszuk, A. Krzystyniak, N. Marek, J. My?liwska, A. Hellmann, First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells. Clin. Immunol. 133, 22-26 (2009).
16. C. G. Brunstein, J. S. Miller, Q. Cao, D. H. McKenna, K. L. Hippen, J. Curtsinger, T. Defor, B. L. Levine, C. H. June, P. Rubinstein, P. B. McGlave, B. R. Blazar, J. E. Wagner, Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: Safety profile and detection kinetics. Blood 117, 1061-1070 (2011).
17. M. Di Ianni, F. Falzetti, A. Carotti, A. Terenzi, F. Castellino, E. Bonifacio, B. Del Papa, T. Zei, R. I. Ostini, D. Cecchini, T. Aloisi, K. Perruccio, L. Ruggeri, C. Balucani, A. Pierini, P. Sportoletti, C. Aristei, B. Falini, Y. Reisner, A. Velardi, F. Aversa, M. F. Martelli, Tregs prevent GVHD and promote immune reconstitution in HLA-haploidentical transplantation. Blood 117, 3921-3928 (2011).
18. X. Wang, L. Lu, S. Jiang, Regulatory T cells: Customizing for the clinic. Sci. Transl. Med. 3, 83ps19 (2011).
19. P. Hoffmann, T. J. Boeld, R. Eder, J. Huehn, S. Floess, G. Wieczorek, S. Olek, W. Dietmaier, R. Andreesen, M. Edinger, Loss of FOXP3 expression in natural human CD4+CD25+ regulatory T cells upon repetitive in vitro stimulation. Eur. J. Immunol. 39, 1088-1097 (2009).
20. Q. Zheng, Y. Xu, Y. Liu, B. Zhang, X. Li, F. Guo, Y. Zhao, Induction of Foxp3 demethylation increases regulatory CD4+CD25+ T cells and prevents the occurrence of diabetes in mice. J. Mol. Med. (Berlin) 87, 1191-1205 (2009).
21. reg balance by hypoxia-inducible factor 1. Cell 146, 772-784 (2011).
22. regcells. J. Exp. Med. 208, 1367-1376 (2011).
23. B. Li, A. Samanta, X. Song, K. T. Iacono, K. Bembas, R. Tao, S. Basu, J. L. Riley, W. W. Hancock, Y. Shen, S. J. Saouaf, M. I. Greene, FOXP3 interactions with histone acetyltransferase and class II histone deacetylases are required for repression. Proc. Natl. Acad. Sci. U.S.A. 104, 4571-4576 (2007).
24. reg functionality by acetylation-mediated Foxp3 protein stabilization. Blood 115, 965-974 (2010).
25. T. Akimova, U. H. Beier, Y. Liu, L. Wang, W. W. Hancock, Histone/protein deacetylases and T-cell immune responses. Blood 119, 2443-2451 (2012).
26. regs. Clin. Immunol. 136, 348-363 (2010).
27. R. Tao, E. F. de Zoeten, E. Ozkaynak, C. Chen, L. Wang, P. M. Porrett, B. Li, L. A. Turka, E. N. Olson, M. I. Greene, A. D. Wells, W. W. Hancock, Deacetylase inhibition promotes the generation and function of regulatory T cells. Nat. Med. 13, 1299-1307 (2007).
28. U. H. Beier, L. Wang, R. Han, T. Akimova, Y. Liu, W. W. Hancock, Histone deacetylases 6 and 9 and sirtuin-1 control foxp3+ regulatory T cell function through shared and isoform-specific mechanisms. Sci. Signal. 5, ra45 (2012).